HSD17B13-IN-22

• UNSPSC Description:

  HSD17B13-IN-22 (Compound 18.03) is an inhibitor of hydroxysteroid 17β-dehydrogenase 13 (HSD17B13). HSD17B13-IN-22 can be used in the research of liver diseases such as hepatitis, liver fibrosis, liver cirrhosis, and hepatocellular carcinoma[1].

• Target Antigen:

  17β-HSD

• Type:

  Reference compound

• Related Pathways:

  Metabolic Enzyme/Protease

• Applications:

  Metabolism-protein/nucleotide metabolism

• Field of Research:

  Metabolic Disease

• Assay Protocol:

  https://www.medchemexpress.com/hsd17b13-in-22.html

• Solubility:

  10 mM in DMSO

• Smiles:

  COC[C@@H]1CN(CCN1C2=NC3=C(C(C4=CC(C(F)(F)F)=C(C(O)=C4F)F)=NN3C)C=N2)S(C)(=O)=O

• Molecular Weight:

  536.48

• References & Citations:

  [1]Johnny Y. Nagasawa, et al. Hsd17b13 inhibitors and uses thereof. WIPO, WO2023043836A1. 2023-03-23.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  2919797-60-5